MIESY vs. RLMD

Last updated Jun 3, 2026

MIESY (Mitsui Engineering & Shipbuilding Co Ltd ADR) and RLMD (Relmada Therapeutics, Inc.) are both stocks. MIESY operates in Aerospace & Defense (Industrials), while RLMD operates in Biotechnology (Healthcare). Over the past 5 years, MIESY returned 43.84%/yr vs -26.71%/yr for RLMD. At a correlation of -0.02, they often move in opposite directions.

Performance

MIESY vs. RLMD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Mitsui Engineering & Shipbuilding Co Ltd ADR (MIESY) and Relmada Therapeutics, Inc. (RLMD). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, MIESY achieves a -35.89% return, which is significantly lower than RLMD's 32.92% return.

MIESY

• 1D: 0.00%
• 1M: -37.34%
• YTD: -35.89%
• 6M: -35.89%
• 1Y: 160.89%
• 3Y*: 98.87%
• 5Y*: 43.84%
• 10Y*: —

RLMD

• 1D: -6.28%
• 1M: -15.97%
• YTD: 32.92%
• 6M: 58.91%
• 1Y: 806.14%
• 3Y*: 31.40%
• 5Y*: -26.71%
• 10Y*: -5.28%

*Multi-year figures are annualized to reflect compound growth (CAGR)

MIESY vs. RLMD - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020
MIESY Mitsui Engineering & Shipbuilding Co Ltd ADR	-35.89%	493.50%	38.78%	82.78%	-36.21%	29.70%	-70.00%
RLMD Relmada Therapeutics, Inc.	32.92%	828.85%	-87.44%	18.62%	-84.51%	-29.75%	-28.84%

Correlation

The correlation between MIESY and RLMD is 0.01, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.01
Correlation (3Y) Calculated over the trailing 3-year period	-0.02
Correlation (5Y) Calculated over the trailing 5-year period	-0.03
Correlation (All Time) Calculated using the full available price history since May 28, 2020	-0.02

Fundamentals

Market Cap MIESY : $2.66B RLMD : $555.95M
EPS MIESY : $386.63 RLMD : -$1.06
PB Ratio MIESY : 0.01 RLMD : 2.54
Total Revenue (TTM) MIESY : $358.09B RLMD : $0.00
Gross Profit (TTM) MIESY : $70.42B RLMD : $0.00
EBITDA (TTM) MIESY : $49.65B RLMD : -$60.34M

Return for Risk

MIESY vs. RLMD — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MIESY

MIESY Risk / Return Rank: 87
MIESY Sharpe Ratio Rank: 63
MIESY Sortino Ratio Rank: 99
MIESY Omega Ratio Rank: 100
MIESY Calmar Ratio Rank: 83
MIESY Martin Ratio Rank: 89

RLMD

RLMD Risk / Return Rank: 98
RLMD Sharpe Ratio Rank: 99
RLMD Sortino Ratio Rank: 98
RLMD Omega Ratio Rank: 96
RLMD Calmar Ratio Rank: 99
RLMD Martin Ratio Rank: 99

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MIESY vs. RLMD - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Mitsui Engineering & Shipbuilding Co Ltd ADR (MIESY) and Relmada Therapeutics, Inc. (RLMD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	MIESY	RLMD	Difference
Sharpe ratio Return per unit of total volatility	0.70	6.62	-5.91
Sortino ratio Return per unit of downside risk	6.64	5.60	+1.04
Omega ratio Gain probability vs. loss probability	4.00	1.61	+2.39
Calmar ratio Return relative to maximum drawdown	3.20	21.13	-17.93
Martin ratio Return relative to average drawdown	11.65	48.78	-37.13
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MIESY vs. RLMD - Sharpe Ratio Comparison

The current MIESY Sharpe Ratio is 0.70, which is lower than the RLMD Sharpe Ratio of 6.62. The chart below compares the historical Sharpe Ratios of MIESY and RLMD, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Sharpe Ratios by Period

	MIESY	RLMD	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	0.70	6.62	-5.91
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.38	-0.23	+0.61
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	-0.05	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.14	-0.16	+0.30

Drawdowns

MIESY vs. RLMD - Drawdown Comparison

The maximum MIESY drawdown since its inception was -78.18%, smaller than the maximum RLMD drawdown of -99.66%. Use the drawdown chart below to compare losses from any high point for MIESY and RLMD.

Drawdown Indicators

	MIESY	RLMD	Difference
Max Drawdown Largest peak-to-trough decline	-78.18%	-99.66%	+21.48%
Max Drawdown (1Y) Largest decline over 1 year	-50.28%	-35.78%	-14.50%
Max Drawdown (3Y) Largest decline over 3 years	-60.56%	-96.30%	+35.74%
Max Drawdown (5Y) Largest decline over 5 years	-60.56%	-99.32%	+38.76%
Max Drawdown (10Y) Largest decline over 10 years	—	-99.50%	—
Current Drawdown Current decline from peak	-50.28%	-91.37%	+41.09%
Average Drawdown Average peak-to-trough decline	-54.64%	-79.70%	+25.06%
Ulcer Index Depth and duration of drawdowns from previous peaks	13.81%	15.50%	-1.69%

Volatility

MIESY vs. RLMD - Volatility Comparison

Mitsui Engineering & Shipbuilding Co Ltd ADR (MIESY) has a higher volatility of 32.21% compared to Relmada Therapeutics, Inc. (RLMD) at 20.29%. This indicates that MIESY's price experiences larger fluctuations and is considered to be riskier than RLMD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	MIESY	RLMD	Difference
Volatility (1M) Calculated over the trailing 1-month period	32.21%	20.29%	+11.92%
Volatility (6M) Calculated over the trailing 6-month period	38.90%	69.52%	-30.62%
Volatility (1Y) Calculated over the trailing 1-year period	233.18%	123.22%	+109.96%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	120.08%	116.20%	+3.88%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	116.10%	114.30%	+1.80%

Dividends

MIESY vs. RLMD - Dividend Comparison

Neither MIESY nor RLMD has paid dividends to shareholders.

Tickers have no history of dividend payments

Financials

Frequently Asked Questions

Can I hold both MIESY and RLMD in my portfolio?

MIESY and RLMD have a correlation of 0.01, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, MIESY or RLMD?

MIESY has higher volatility (32.21%) compared to RLMD (20.29%). In terms of maximum drawdown, MIESY dropped -78.18% vs RLMD's -99.66%.

Which has better risk-adjusted returns?

RLMD currently has the higher Sharpe Ratio (6.62 vs 0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.